Acumen Pharmaceuticals (ABOS.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Nov13

Citigroup Analyst Maintains Buy Rating on Acumen Pharmaceuticals

11:22

Nov12

Acumen Pharmaceuticals released FY2025 Q3 earnings during market hours on November 12, 2025 (EST), with actual revenue USD 0 (forecast USD 0) and actual EPS USD -0.4366 (forecast USD -0.58)

21:00

Acumen Pharmaceuticals released FY2025 9 Months Earnings on November 12 During-Market EST, actual revenue USD 0, actual EPS USD -1.5884

21:00

Nov5

Acumen Pharmaceuticals to Release FY2025 Q3 Earnings on November 12 During-Market EST, Forecast EPS USD -0.58

00:07

Oct17

Meacham Maintains Strong Buy Rating on Acumen Pharmaceuticals

10:52

Oct16

Shrader Analyst Focuses on Healthcare Industry Stocks

10:56

Schedules & Filings

Schedules

Filings

Nov12

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -26.45 M, EPS -0.4366

Aug12

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -40.95 M, EPS -0.676

May13

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -28.8 M, EPS -0.4757

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change